CASTLEARK MANAGEMENT LLC – Halozyme Therapeutics, Inc. Transaction History
CASTLEARK MANAGEMENT LLC portfolio value:
$8.57M
portfolio value
CASTLEARK MANAGEMENT LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.28% | 12.81K shares | -403K | $39.54 | 216.75K |
| Q2 2022 | share | Increase | 0.00% | 203.94K shares | 8.97M | $44 | 203.94K |
| Q4 2021 | share | Decrease | -100.00% | -219.78K shares | -8.94M | $40.32 | 0 |
| Q3 2021 | share | Decrease | -30.84% | -98K shares | -5.49M | $40.68 | 219.78K |
| Q2 2021 | share | Decrease | -26.20% | -112.81K shares | -3.52M | $45.41 | 317.78K |
| Q1 2021 | share | Decrease | -13.73% | -68.54K shares | -3.36M | $41.69 | 430.60K |
| Q4 2020 | share | Decrease | -16.62% | -99.47K shares | 5.58M | $42.71 | 499.14K |
| Q3 2020 | share | Increase | +6.67% | 37.43K shares | 687K | $26.28 | 598.61K |
| Q2 2020 | share | Increase | +28.16% | 123.31K shares | 7.16M | $26.81 | 561.18K |
| Q1 2020 | share | Increase | 0.00% | 437.87K shares | 7.87M | $17.99 | 437.87K |
| Q3 2018 | share | Decrease | -100.00% | -423.30K shares | -7.14M | $18.17 | 0 |
| Q2 2018 | share | Decrease | -2.21% | -9.57K shares | -1.33M | $16.87 | 423.30K |
| Q1 2018 | share | Increase | +23.56% | 82.52K shares | 1.38M | $19.59 | 432.88K |
| Q4 2017 | share | Increase | +50.43% | 117.45K shares | 3.05M | $20.26 | 350.35K |
| Q3 2017 | share | Increase | 0.00% | 232.90K shares | 4.04M | $17.37 | 232.90K |